Safe And Effective Treatment For Acute Repetitive Seizures

June 24, 1998

A unique gel formulation of diazepam safely reduces the severity of acute repetitive seizure episodes in both children and adults, according to a study published in the June 25, 1998, issue of The New England Journal of Medicine* and funded by the National Institute of Neurological Disorders and Stroke (NINDS). Acute repetitive seizures are episodes of multiple seizures that differ from the individual's usual seizure pattern and are often distinctly recognizable by the patient's family and caregivers. The repetitive seizures may occur serially or in clusters and may last minutes to hours. Acute repetitive seizures may require emergency treatment, especially if they progress to status epilepticus, a potentially fatal condition in which a seizure is sustained.

Seizures occur as a result of abnormal electrical activity in the brain. Epilepsy, a common neurological disorder marked by repeated seizures, affects more than 2 million Americans. Benzodiazepines, a class of drugs that includes diazepam and lorazepam, are generally agreed to be the treatment of choice for acute repetitive seizures.

"This new method of treatment clearly reduces the number of seizures for both children and adults and protects patients from seizure recurrence," said Philip H. Sheridan, M.D., Chief of the NINDS Epilepsy Branch. "Informed caregivers are often able to recognize the onset of a seizure cluster. Now, with this preparation, they can be trained to administer treatment privately, quickly, and safely."

The study was a randomized, double-blind study of 91 individuals with acute repetitive seizures. It was conducted by investigators collaborating at ten university medical centers nationwide. The NINDS provided support to six of the 10 centers participating in the Rectal Administration of Diazepam for Acute Repetitive Seizures (RADARS) study. A frequently reported side effect was sleepiness, common to most medicines used to treat epilepsy.

The new preparation is marketed in a Quick-Dose (TM) delivery system as Diastatâ (diazepam rectal gel) by Athena Neurosciences, Inc., a company based in South San Francisco. In addition to the new gel formulation, administered with an applicator, diazepam is also sold in oral form. Administration of diazepam in oral form is problematic for both physicians and family members because the patient must be alert in order to swallow.

"This is a safe and effective way of addressing an urgent health condition and one that enables flexible, convenient treatment outside of a hospital or clinic, including the patient's home," says Dr. Sheridan. "This trial is a striking example of how a relatively small research investment, in this case about $850,000, will save American families substantial amounts of money by enabling patients to stay out of hospital emergency rooms and to receive treatment in their homes. It is also an excellent example of collaboration between a private company, clinical investigators, and the National Institutes of Health in order to meet a medical need."

The NINDS, one of the National Institutes of Health located in Bethesda, Maryland, is the nation's leading supporter of research on the brain and the nervous system and a lead agency for the Congressionally designated Decade of the Brain.

*Dreifuss, F.E. [deceased], Rosman, N.P., Cloyd, J.C., Pellock, J.M., Kuzniecky, R.I., Lo, W.D., Matsuo, F., Sharp, G.B., Conry, J.A., Bergen, D.C., Bell, W.E. "A Comparison of Rectal Diazepam Gel and Placebo for Acute Repetitive Seizures." The New England Journal of Medicine, June 25, 1998, Vol. 338, No. 26, pp. 1869-1875.

This release will be available on the World Wide Web at http://www.ninds.nih.gov.
-end-


NIH/National Institute of Neurological Disorders and Stroke

Related Seizures Articles from Brightsurf:

Hallucinations in people with seizures may point to suicide risk
A study from scientists at Trinity College Dublin and Royal College of Surgeons in Ireland shows that 8% of individuals with a history of seizures report hallucinations, including experiences of hearing or seeing things that are not based in reality.

Epilepsy: Seizures not forecastable as expected
Epileptic seizures can probably not be predicted by changes in brain wave patterns that were previously assumed to be characteristic precursors.

Predicting epileptic seizures might be more difficult than previously thought
By studying the brain dynamics of 28 subjects with epilepsy, scientists demonstrated there is no evidence for a previously suspected warning sign for seizures known as 'critical slowing down,' which refers to characteristic changes in the behavior of a complex system that approaches a theoretical tipping point; when this point is exceeded, there can be impactful and devastating changes.

Gene protective against fruit fly heat-induced seizures may explain some human seizures
Researchers identified a gene in fruit flies that helps prevent the hyperexcitability of specific neurons that trigger seizures.

Rethinking seizures associated with cardiac disease
Research from Washington University in St. Louis finds that mutations of a gene implicated in long QT syndrome in humans may trigger seizures because of their direct effects on certain classes of neurons in the brain -- independent from what the genetic mutations do to heart function.

UTSA reduces seizures by removing newborn neurons
Epileptic seizures happen in one of every 10 people who have experienced a traumatic brain injury (TBI).

Reducing seizures by removing newborn neurons
Removing new neurons born after a brain injury reduces seizures in mice, according to new research in JNeurosci.

Inducing seizures to stop seizures
Surgery is the only way to stop seizures in 30 per cent of patients with focal drug-resistant epilepsy.

New research could help predict seizures before they happen
A new study has found a pattern of molecules that appear in the blood before a seizure happens.

New drug could help treat neonatal seizures
A new drug that inhibits neonatal seizures in rodent models could open up new avenues for the treatment of epilepsy in human newborns.

Read More: Seizures News and Seizures Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.